QUOTE AND NEWS
SeekingAlpha  Jun 16  Comment 
Motley Fool  Feb 6  Comment 
Intrexon went shopping in January, but Wall Street wasn't buying.
Benzinga  Jan 25  Comment 
Telsey Advisory Group lowered the price target for Kate Spade & Co (NYSE: KATE) from $23 to $21. Kate Spade shares closed at $18.61 on Tuesday. FBR Capital cut Verizon Communications Inc. (NYSE: VZ) price target from $57 to $52. Verizon...
Benzinga  Jan 25  Comment 
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday, January 24, 2017. Coke Said to be Interested in Kellogg Acquisition The Rumor: Shares of Kellogg Company (NYSE: K) rose to a high of $72.87 on...
FierceBiotech  Jan 25  Comment 
Intrexon to buy floundering GenVec for gene delivery tech nick.paul.taylor Wed, 01/25/2017 - 04:46
Reuters  Jan 24  Comment 
* If merger agreement is terminated by either party, Genvec must pay Intrexon a termination fee equal to $550,000 - SEC filing Source text: (http://bit.ly/2jbIZR1) Further company coverage:
GenEng News  Jan 24  Comment 
Intrexon has agreed to acquire GenVec, the developer of the AdenoVerseā„¢ gene delivery platform, for an undisclosed price, the companies said today. The deal is designed to enable Intrexon to enhance its broad gene transfer capabilities...
Benzinga  Jan 10  Comment 
Shares of GenVec Inc (NASDAQ: GNVC) are set to record 200-percent gains after signing an option deal last week with Washington University in St. Louis. The option deal is to license intellectual property and technology related to gene editing and...
newratings.com  Jan 10  Comment 
JERUSALEM (dpa-AFX) - The following are the biotech stocks that made their way onto the Day's Gainers & Losers' list of January 9, 2017. 1. Diffusion Pharmaceuticals Inc. (DFFN) Gained 176.70% to close Monday's trading at...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki